BIRMINGHAM, Ala., June 23 /PRNewswire/ -- The patented VAP® Cholesterol Test helps physicians pinpoint the most effective cholesterol and heart disease risk-lowering treatments in Type 2 diabetes patients, providing valuable and potentially life-saving information to diabetics.

Cardio-diagnostic company adds new line of heart disease and diabetes tests to complement advanced cholesterol profile BIRMINGHAM, Ala., April 20 /PRNewswire/ -- Atherotech, Inc.

Heart disease and diabetes markers to complement VAP advanced cholesterol profile ORLANDO, Fla.

Cardio-diagnostic company adds new apoAI measurement and apoB/apoAI ratio to advanced lipid profile for heart disease risk stratification BIRMINGHAM, Ala., March 17 /PRNewswire/ -- Atherotech, Inc., today announced it will be exhibiting its VAP(R) Cholesterol Test in booth #1263 at ACC.09, the American College of Cardiology (ACC) 58th Annual Scientific Session Exposition.

BIRMINGHAM, Ala., Aug.